On the 15th of December the independent committee of Sky has approved to sell to 21st Century Fox 60.4% of its equity ownership at £10.75 per share. The agreement comes after two rejections by the committee in the previous days, and it represents the latest attempt of the Murdoch Brothers to acquire full ownership of … Continue reading Foxes May Lose Their Hair, But Not Their Goals
Author: bsmac
LSE – DB merger: a crucial step towards Capital Markets Union
London Stock Exchange Group (LSE:LSE) and Deutsche Börse (DB1X.N:GER) have agreed to merge and give birth to the largest European stock exchange group with a combined market capitalization of over $6tn. Industry Overview Not only have the financial markets been exceptionally turbulent since the last quarter of 2015 but also the exchange operators that are … Continue reading LSE – DB merger: a crucial step towards Capital Markets Union
The Marriott – Starwood Deal The Golden Age for M&A in the Hospitality Sector
On November 16 2015, Marriott and Starwood agreed to an acquisition transaction valued at $12.2bn that will create the world’s largest hotel company so far. Drivers of the deal Marriott International (MAR) lining up a takeover bid for Starwood hotels and Resorts (HOT) caught everyone by surprise since Marriott did not take part in the … Continue reading The Marriott – Starwood Deal The Golden Age for M&A in the Hospitality Sector
ChemChina still in the run for its global primacy, this time is the agrochemical giant Syngenta to fall in its arms
On February 3rd, 2016 ChemChina announced its acquisition of Syngenta’s 100% outstanding share capital at $465 per ordinary share and a special dividend of CHF 5 to be paid only conditionally on the closing of the transaction. The deal comes after several failed acquisition attempts by Monsanto towards Syngenta, declined due to a reportedly too … Continue reading ChemChina still in the run for its global primacy, this time is the agrochemical giant Syngenta to fall in its arms
Abbott’s acquisition of Alere: reshaping the market for rapid medical tests
Abbott Laboratories (NYSE:ABT) announced on February 1st, 2016 the acquisition of Alere (NYSE:ALR). The deal comes just few days after Abbott reported a drop of 15% in its profits for the final quarter of 2015, mainly linked to the stronger dollar effects on its results in the Emerging Markets where it sells its products. The … Continue reading Abbott’s acquisition of Alere: reshaping the market for rapid medical tests
Top of the Pops: Banco Popolare and BPM merge to create Italy’s third largest bank
After months of intense talks, on March 23, Banca Popolare di Milano (PMI:IM) and Banco Popolare (BP:IM) agreed to merge and to form the third largest bank in Italy by assets (€170bn). The deal comes after a tacit approval by the ECB and is probably only the first step of an anticipated bigger consolidation process. … Continue reading Top of the Pops: Banco Popolare and BPM merge to create Italy’s third largest bank
Anti-Netflix plan: Vivendi – Mediaset Premium
On the 8th of April, Mediaset agreed to sell its pay-tv business to the European media conglomerate Vivendi, creating a partnership that is set to trigger the long-awaited consolidation in the industry. In this article, we took in consideration the main drivers of the deal, verifying coherence with industry trends, underlining the structure and trying … Continue reading Anti-Netflix plan: Vivendi – Mediaset Premium
From Bratislava with Love: Slovak nuclear on sale
On December 18th Enel announced an agreement with EPH for the sale of its 66% stake in the Slovak subsidiary Slovenské Elektrárne. Discussions are still ongoing about the possible purchase of a 17% stake by the Slovak Government to maintain the control of the company, the first electricity producer and distributor in Slovakia. Companies overview … Continue reading From Bratislava with Love: Slovak nuclear on sale
Pfizer – Allergan
A new Pharma Mega-Deal making Botox and Viagra join forces. On November 23, 2015, Pfizer announced its $160bn tie-up with Allergan to form the world’s biggest pharmaceutical company by sales. Industry Overview Even though recent M&A activity has started to slow down in the healthcare sector, the announced merger shows that the M&A frenzy is … Continue reading Pfizer – Allergan
You must be logged in to post a comment.